Delivery Order SPE2DB20D2002-SPE2DB24FL66Z
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award (ID SPE2DB20D7066|SPE2DB25FC2CC) was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,771.40 firm fixed-price delivery order is for the supply of ROTARIX vaccine oral syringes 1.5mL, to be delivered by January 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN49F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,149.90 firm fixed-price delivery order is for the supply of the ROTARIX VACCINE ORAL SYRINGE 1.5ML. The ultimate completion date for this contract is February 5, 2025. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order (SPE2DB20D3303|SPE2DB24FZ9C1) from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,642.64 firm fixed-price contract is for the delivery of the ROTARIX VACCINE ORAL SYRINGE 1.5ML product to support military healthcare programs. The contract has a period of performance through June 6, 2024 and is not designated as a set-aside. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award, with the ID SPE2DB24D1007|SPE2DB25FBZYS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringe 1.5ML, with a ceiling value of $1,464.10 and a completion date of January 22, 2025. This is a firm fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the ROTARIX vaccine oral syringe 1.5ML to the Defense Logistics Agency (DLA). The $21,531.21 firm fixed-price delivery order contract has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the ROTARIX VACCINE ORAL SYRINGE 1.5ML to the Defense Logistics Agency (DLA). The $9,609.02 firm fixed-price delivery order has a completion date of June 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables efficient...
This federal contract award, with ID SPE2DB22D2218|SPE2DB25FR2DA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $13,769.94 firm fixed-price delivery order is for the supply of ROTARIX VACCINE ORAL SYRINGES 1.5ML, with a period of performance through March 17, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, identified as SPE2DB22D3301|SPE2DB24FX4BK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringe 1.5ML, a critical medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $32,889.26, and has an ultimate completion date of October 23, 2023. This award is not...
This federal contract award, SPE2DB22D3004|SPE2DB25FPL14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ROTARIX vaccine oral syringes. The contract, valued at $7,003.72, is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $5,906.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTARIX vaccine oral syringes, 1.5 mL, to support military healthcare programs. The contract has an ultimate completion date of January 9, 2025 and is a firm fixed-price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) held by...